May-June 2019 (Volume 20, Number 3) : PDF
Evaluating data quality: Integrity, reliability, accessibility
Not all data are created equal, and clinical trial professionals must be able to recognize when the data they collect have value and when they don’t.
A new look at clinical trial compensation for participants
When it comes to offering to pay clinical trial subjects to participate, the line between compensation and coercion is difficult to draw but all too easy to cross.
The case for paying trial completion bonuses
Completion bonuses are one particular type of compensation for clinical trial participants that institutional review boards (IRBs) sometimes reject. Researchers recently argued that with the appropriate safeguards, however, “completion bonuses” are not coercive and are unlikely to be unduly influential.